Report Detail

Pharma & Healthcare COVID-19 Impact on Global Sleeping Pills (Prescription Drugs), Market Insights and Forecast to 2026

  • RnM4080162
  • |
  • 26 June, 2020
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Sleeping Pills (Prescription Drugs) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sleeping Pills (Prescription Drugs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Sleeping Pills (Prescription Drugs) market is segmented into
Zolpidem
Eszopiclone (Lunesta)
Ramelteon (Rozerem)
Ativan (lorazepam)
Adapin (doxepin)

Segment by Application, the Sleeping Pills (Prescription Drugs) market is segmented into
Hospital Pharmacy
Retail Pharmacy

Regional and Country-level Analysis
The Sleeping Pills (Prescription Drugs) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sleeping Pills (Prescription Drugs) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Sleeping Pills (Prescription Drugs) Market Share Analysis
Sleeping Pills (Prescription Drugs) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Sleeping Pills (Prescription Drugs) business, the date to enter into the Sleeping Pills (Prescription Drugs) market, Sleeping Pills (Prescription Drugs) product introduction, recent developments, etc.
The major vendors covered:
Sanofi
Abbott Laboratories
Takeda Pharmaceutical
Apotex
Aurobindo Pharma
Actellon Pharmaceuticals
Allegiant Health
Cayman Chemical
Ambitropin
Hayao


1 Study Coverage

  • 1.1 Sleeping Pills (Prescription Drugs) Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Sleeping Pills (Prescription Drugs) Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Sleeping Pills (Prescription Drugs) Market Size Growth Rate by Type
    • 1.4.2 Zolpidem
    • 1.4.3 Eszopiclone (Lunesta)
    • 1.4.4 Ramelteon (Rozerem)
    • 1.4.5 Ativan (lorazepam)
    • 1.4.6 Adapin (doxepin)
  • 1.5 Market by Application
    • 1.5.1 Global Sleeping Pills (Prescription Drugs) Market Size Growth Rate by Application
    • 1.5.2 Hospital Pharmacy
    • 1.5.3 Retail Pharmacy
  • 1.6 Coronavirus Disease 2019 (Covid-19): Sleeping Pills (Prescription Drugs) Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Sleeping Pills (Prescription Drugs) Industry
      • 1.6.1.1 Sleeping Pills (Prescription Drugs) Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Sleeping Pills (Prescription Drugs) Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Sleeping Pills (Prescription Drugs) Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Sleeping Pills (Prescription Drugs) Market Size Estimates and Forecasts
    • 2.1.1 Global Sleeping Pills (Prescription Drugs) Revenue 2015-2026
    • 2.1.2 Global Sleeping Pills (Prescription Drugs) Sales 2015-2026
  • 2.2 Sleeping Pills (Prescription Drugs) Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Sleeping Pills (Prescription Drugs) Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Sleeping Pills (Prescription Drugs) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Sleeping Pills (Prescription Drugs) Competitor Landscape by Players

  • 3.1 Sleeping Pills (Prescription Drugs) Sales by Manufacturers
    • 3.1.1 Sleeping Pills (Prescription Drugs) Sales by Manufacturers (2015-2020)
    • 3.1.2 Sleeping Pills (Prescription Drugs) Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Sleeping Pills (Prescription Drugs) Revenue by Manufacturers
    • 3.2.1 Sleeping Pills (Prescription Drugs) Revenue by Manufacturers (2015-2020)
    • 3.2.2 Sleeping Pills (Prescription Drugs) Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Sleeping Pills (Prescription Drugs) Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Sleeping Pills (Prescription Drugs) Revenue in 2019
    • 3.2.5 Global Sleeping Pills (Prescription Drugs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Sleeping Pills (Prescription Drugs) Price by Manufacturers
  • 3.4 Sleeping Pills (Prescription Drugs) Manufacturing Base Distribution, Product Types
    • 3.4.1 Sleeping Pills (Prescription Drugs) Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Sleeping Pills (Prescription Drugs) Product Type
    • 3.4.3 Date of International Manufacturers Enter into Sleeping Pills (Prescription Drugs) Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Sleeping Pills (Prescription Drugs) Market Size by Type (2015-2020)
    • 4.1.1 Global Sleeping Pills (Prescription Drugs) Sales by Type (2015-2020)
    • 4.1.2 Global Sleeping Pills (Prescription Drugs) Revenue by Type (2015-2020)
    • 4.1.3 Sleeping Pills (Prescription Drugs) Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Sleeping Pills (Prescription Drugs) Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Sleeping Pills (Prescription Drugs) Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Sleeping Pills (Prescription Drugs) Revenue Forecast by Type (2021-2026)
    • 4.2.3 Sleeping Pills (Prescription Drugs) Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Sleeping Pills (Prescription Drugs) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Sleeping Pills (Prescription Drugs) Market Size by Application (2015-2020)
    • 5.1.1 Global Sleeping Pills (Prescription Drugs) Sales by Application (2015-2020)
    • 5.1.2 Global Sleeping Pills (Prescription Drugs) Revenue by Application (2015-2020)
    • 5.1.3 Sleeping Pills (Prescription Drugs) Price by Application (2015-2020)
  • 5.2 Sleeping Pills (Prescription Drugs) Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Sleeping Pills (Prescription Drugs) Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Sleeping Pills (Prescription Drugs) Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Sleeping Pills (Prescription Drugs) Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Sleeping Pills (Prescription Drugs) by Country
    • 6.1.1 North America Sleeping Pills (Prescription Drugs) Sales by Country
    • 6.1.2 North America Sleeping Pills (Prescription Drugs) Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Type
  • 6.3 North America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Sleeping Pills (Prescription Drugs) by Country
    • 7.1.1 Europe Sleeping Pills (Prescription Drugs) Sales by Country
    • 7.1.2 Europe Sleeping Pills (Prescription Drugs) Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Sleeping Pills (Prescription Drugs) Market Facts & Figures by Type
  • 7.3 Europe Sleeping Pills (Prescription Drugs) Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Sleeping Pills (Prescription Drugs) by Region
    • 8.1.1 Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Region
    • 8.1.2 Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Sleeping Pills (Prescription Drugs) Market Facts & Figures by Type
  • 8.3 Asia Pacific Sleeping Pills (Prescription Drugs) Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Sleeping Pills (Prescription Drugs) by Country
    • 9.1.1 Latin America Sleeping Pills (Prescription Drugs) Sales by Country
    • 9.1.2 Latin America Sleeping Pills (Prescription Drugs) Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Type
  • 9.3 Central & South America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Sleeping Pills (Prescription Drugs) by Country
    • 10.1.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country
    • 10.1.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Facts & Figures by Type
  • 10.3 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Sanofi
    • 11.1.1 Sanofi Corporation Information
    • 11.1.2 Sanofi Description, Business Overview and Total Revenue
    • 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Sleeping Pills (Prescription Drugs) Products Offered
    • 11.1.5 Sanofi Recent Development
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Corporation Information
    • 11.2.2 Abbott Laboratories Description, Business Overview and Total Revenue
    • 11.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Abbott Laboratories Sleeping Pills (Prescription Drugs) Products Offered
    • 11.2.5 Abbott Laboratories Recent Development
  • 11.3 Takeda Pharmaceutical
    • 11.3.1 Takeda Pharmaceutical Corporation Information
    • 11.3.2 Takeda Pharmaceutical Description, Business Overview and Total Revenue
    • 11.3.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Products Offered
    • 11.3.5 Takeda Pharmaceutical Recent Development
  • 11.4 Apotex
    • 11.4.1 Apotex Corporation Information
    • 11.4.2 Apotex Description, Business Overview and Total Revenue
    • 11.4.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Apotex Sleeping Pills (Prescription Drugs) Products Offered
    • 11.4.5 Apotex Recent Development
  • 11.5 Aurobindo Pharma
    • 11.5.1 Aurobindo Pharma Corporation Information
    • 11.5.2 Aurobindo Pharma Description, Business Overview and Total Revenue
    • 11.5.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Products Offered
    • 11.5.5 Aurobindo Pharma Recent Development
  • 11.6 Actellon Pharmaceuticals
    • 11.6.1 Actellon Pharmaceuticals Corporation Information
    • 11.6.2 Actellon Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.6.3 Actellon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Products Offered
    • 11.6.5 Actellon Pharmaceuticals Recent Development
  • 11.7 Allegiant Health
    • 11.7.1 Allegiant Health Corporation Information
    • 11.7.2 Allegiant Health Description, Business Overview and Total Revenue
    • 11.7.3 Allegiant Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Allegiant Health Sleeping Pills (Prescription Drugs) Products Offered
    • 11.7.5 Allegiant Health Recent Development
  • 11.8 Cayman Chemical
    • 11.8.1 Cayman Chemical Corporation Information
    • 11.8.2 Cayman Chemical Description, Business Overview and Total Revenue
    • 11.8.3 Cayman Chemical Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Cayman Chemical Sleeping Pills (Prescription Drugs) Products Offered
    • 11.8.5 Cayman Chemical Recent Development
  • 11.9 Ambitropin
    • 11.9.1 Ambitropin Corporation Information
    • 11.9.2 Ambitropin Description, Business Overview and Total Revenue
    • 11.9.3 Ambitropin Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Ambitropin Sleeping Pills (Prescription Drugs) Products Offered
    • 11.9.5 Ambitropin Recent Development
  • 11.10 Hayao
    • 11.10.1 Hayao Corporation Information
    • 11.10.2 Hayao Description, Business Overview and Total Revenue
    • 11.10.3 Hayao Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Hayao Sleeping Pills (Prescription Drugs) Products Offered
    • 11.10.5 Hayao Recent Development
  • 11.1 Sanofi
    • 11.1.1 Sanofi Corporation Information
    • 11.1.2 Sanofi Description, Business Overview and Total Revenue
    • 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Sleeping Pills (Prescription Drugs) Products Offered
    • 11.1.5 Sanofi Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Sleeping Pills (Prescription Drugs) Market Estimates and Projections by Region
    • 12.1.1 Global Sleeping Pills (Prescription Drugs) Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Sleeping Pills (Prescription Drugs) Revenue Forecast by Regions 2021-2026
  • 12.2 North America Sleeping Pills (Prescription Drugs) Market Size Forecast (2021-2026)
    • 12.2.1 North America: Sleeping Pills (Prescription Drugs) Sales Forecast (2021-2026)
    • 12.2.2 North America: Sleeping Pills (Prescription Drugs) Revenue Forecast (2021-2026)
    • 12.2.3 North America: Sleeping Pills (Prescription Drugs) Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Sleeping Pills (Prescription Drugs) Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Sleeping Pills (Prescription Drugs) Sales Forecast (2021-2026)
    • 12.3.2 Europe: Sleeping Pills (Prescription Drugs) Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Sleeping Pills (Prescription Drugs) Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Sleeping Pills (Prescription Drugs) Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Sleeping Pills (Prescription Drugs) Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Sleeping Pills (Prescription Drugs) Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Sleeping Pills (Prescription Drugs) Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Sleeping Pills (Prescription Drugs) Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Sleeping Pills (Prescription Drugs) Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Sleeping Pills (Prescription Drugs) Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Sleeping Pills (Prescription Drugs) Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Sleeping Pills (Prescription Drugs) Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Sleeping Pills (Prescription Drugs) Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Sleeping Pills (Prescription Drugs) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Sleeping Pills (Prescription Drugs) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Sleeping Pills (Prescription Drugs) Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Sleeping Pills (Prescription Drugs). Industry analysis & Market Report on COVID-19 Impact on Global Sleeping Pills (Prescription Drugs) is a syndicated market report, published as COVID-19 Impact on Global Sleeping Pills (Prescription Drugs), Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Sleeping Pills (Prescription Drugs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,108.30
    4,662.45
    6,216.60
    3,627.00
    5,440.50
    7,254.00
    596,232.00
    894,348.00
    1,192,464.00
    325,377.00
    488,065.50
    650,754.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report